透過您的圖書館登入
IP:18.220.136.165
  • 期刊

相思樹胰蛋白酶抑制劑藉由抑制ERK 1/2磷酸化和活化caspase-3誘導HT-29人類結腸癌細胞凋亡

Acacia Confusa Trypsin Inhibitor Induced Apoptosis of HT-29 Human Colon Cancer Cells via Inhibition of ERK 1/2 Phosphorylation and Caspase-3 Activation

摘要


相思樹胰蛋白酶抑制劑(ACTI)是屬於Kunitz型胰蛋白酶抑制劑家族,由兩條多肽鏈組成,分子量為19.4 kDa。ACTI對人類結腸癌細胞(HT-29)表現出的細胞毒性作用確切機制尚不清楚。我們分別利用MTT和流式細胞儀分析證實ACTI能夠抑制HT-29細胞的生長和誘導細胞凋亡,隨著處理ACTI的濃度及時間增加而愈顯著。在濃度為5 μM ACTI處理HT-29細胞48小時後,caspase-3活性增加,加入Z-VAD-fmk(一種廣效型caspase抑制劑)能阻止ACTI誘導的細胞凋亡;而以PD98059(一種ERK 1/2抑制劑)處理,則能促進ACTI誘導的細胞凋亡。另外,以ACTI處理HT-29細胞會抑制ERK 1/2的磷酸化並促進細胞色素c釋放到細胞液中。此外,先以PD98059處理HT-29細胞後,能促進ACTI誘導caspase-3活性。這些結果顯示,ACTI可藉由抑制ERK 1/2磷酸化,使得位於粒線體中的細胞色素c釋放到細胞液,進而活化caspase-3而引起HT-29細胞凋亡。

並列摘要


Acacia confusa trypsin inhibitor (ACTI) is a Kunitz-type family two-chain trypsin inhibitor with an MWr of 19.4 kD. ACTI exhibits cytotoxic effects on human colon cancer cells (HT-29) although the exact mechanism of this action of ACTI is unknown. We report here that ACTI strongly inhibits the growth and induced apoptosis of HT-29 cells in both a time- and concentration-dependent manner, determined by MTT and flow cytometric analysis, respectively. Caspase-3 activity increased 48 h after treatment with ACTI at 5 μM concentration. Caspase inhibitor, Z-VAD-fmk, prevented ACTI-induced apoptosis, while PD98059, an extracellular signal-regulated kinase 1/2 (ERK 1/2) inhibitor, promoted ACTI-induced apoptosis. Additionally, treatment with ACTI inhibited the phosphorylation of ERK and promoted the release of cytochrome c into cytosol. Furthermore, pretreatment with PD98059 further promoted ACTI-induced caspase-3 activity. These results show that ACTI causes the apoptosis of HT-29 cells by inhibiting ERK 1/2 phosphorylation, releasing cytochrome c into the cytosol and, in turn, activating caspase-3.

並列關鍵字

ACTI caspase-3 ERK 1/2 apoptosis HT-29 cells cytochrome c

延伸閱讀